Fraser John K, Wulur Isabella, Alfonso Zeni, Hedrick Marc H
Cytori Therapeutics Inc., 3020 Callan Road, San Diego, CA 92121, USA.
Trends Biotechnol. 2006 Apr;24(4):150-4. doi: 10.1016/j.tibtech.2006.01.010. Epub 2006 Feb 20.
Adipose tissue can be harvested in large amounts with minimal morbidity. It contains numerous cells types, including adipocytes, preadipocytes, vascular endothelial cells and vascular smooth muscle cells; it also contains cells that have the ability to differentiate into several lineages, such as fat, bone, cartilage, skeletal, smooth, and cardiac muscle, endothelium, hematopoietic cells, hepatocytes and neuronal cells. Cloning studies have shown that some adipose-derived stem cells (ADSCs) have multilineage differentiation potential. ADSCs are also capable of expressing multiple growth factors, including vascular endothelial growth factor and hepatocyte growth factor. Early, uncontrolled, non-randomized clinical research, applying fresh adipose-derived cells into a cranial defect or undifferentiated ADSCs into fistulas in Crohn's disease, has shown healing and an absence of side effects. The combination of these properties, and the large quantity of cells that can be obtained from fat, suggests that this tissue will be a useful tool in biotechnology.
脂肪组织可以大量获取,且发病率极低。它包含多种细胞类型,包括脂肪细胞、前脂肪细胞、血管内皮细胞和血管平滑肌细胞;它还含有能够分化为多种谱系的细胞,如脂肪、骨骼、软骨、骨骼肌、平滑肌和心肌、内皮、造血细胞、肝细胞和神经细胞。克隆研究表明,一些脂肪来源干细胞(ADSCs)具有多谱系分化潜能。ADSCs还能够表达多种生长因子,包括血管内皮生长因子和肝细胞生长因子。早期、未受控制的非随机临床研究,将新鲜的脂肪来源细胞应用于颅骨缺损或未分化的ADSCs应用于克罗恩病的瘘管,已显示出愈合且无副作用。这些特性的结合,以及可从脂肪中获得的大量细胞,表明该组织将成为生物技术中的一种有用工具。